Scivita Medical Completes Series B Financing of Nearly RMB0.4 Billion
Accelerating the Strategic Layout of Globalization
HONG KONG, Aug 5, 2021 - (ACN Newswire) - Following the completion of series A round financing, with the acceleration of the research and development and commercialization of endoscopy products, Scivita Medical Technology Co., Ltd. ("Scivita Medical") announced today that it has received nearly RMB0.4 Billion in Series B financing, with new investors such as Hudson Bay Capital Management and Prime Capital, as well as continuous support from existing shareholders such as GL Ventures, Lilly Asia Ventures and Matrix Partners China. This round of financing will continue to be used for research and...